MedTrace Logo

Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids

NCT01967433 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-03-11

Study results available
· View outcomes & findings →

Summary

To access the efficacy of adding diphenhydramine as adjunct to improve sedation and to reduce the amount of standard sedatives used during colonoscopy in patients on chronic opioids.

Conditions

  • Colonoscopy
  • Adjunct Anesthesia Medication

Interventions

DRUG

Diphenhydramine

DRUG

Placebo

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Salman Nusrat, MD · University of Oklahoma

  • Mohammad Madhoun, MD MS · Univeristy of Oklahoma Health Sciences Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2018-03-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01967433 on ClinicalTrials.gov